Researcher.Life Logo

Antibodies : Impact Factor & More

eISSN: 2073-4468pISSN: 2073-4468
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Antibodies

Antibodies Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Multidisciplinary Digital Publishing Institute (MDPI)
Language English
Frequency Quarterly
Article Processing ChargesCHF 1600
Publication Time6
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Antibodies ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Antibodies

Ca13Mab-17, a Novel Anti-Cadherin-13 Monoclonal Antibody for Versatile Applications
  • 11 May 2026
  • Antibodies
A Recombinant Antibody Against Human DRP1 Serine 616 Phosphorylation Enables Detection of BRAFV600E-Associated Mitochondrial Division in Cancer.
  • 20 Apr 2026
  • Antibodies (Basel, Switzerland)
Brain Delivery of Antibody-Derived Biologicals for Alzheimer's Disease: An Updated Narrative Review.
  • 17 Apr 2026
  • Antibodies (Basel, Switzerland)
Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review.
  • 16 Apr 2026
  • Antibodies (Basel, Switzerland)
IMGT® Nomenclature of Immunoglobulins (IG) or Antibodies and T Cell Receptors (TR): A Common Language for Immunoinformatics and Artificial Intelligence (AI).
  • 15 Apr 2026
  • Antibodies (Basel, Switzerland)
Development of a Human IgG1 Monoclonal Antibody Targeting Transferrin Receptor 1 for Antitumor Drug Delivery.
  • 13 Apr 2026
  • Antibodies (Basel, Switzerland)
Ca13Mab-17, a Novel Anti-Cadherin-13 Monoclonal Antibody for Versatile Applications
  • 11 May 2026
  • Antibodies
A Recombinant Antibody Against Human DRP1 Serine 616 Phosphorylation Enables Detection of BRAFV600E-Associated Mitochondrial Division in Cancer.
  • 20 Apr 2026
  • Antibodies (Basel, Switzerland)
Brain Delivery of Antibody-Derived Biologicals for Alzheimer's Disease: An Updated Narrative Review.
  • 17 Apr 2026
  • Antibodies (Basel, Switzerland)
Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review.
  • 16 Apr 2026
  • Antibodies (Basel, Switzerland)
IMGT® Nomenclature of Immunoglobulins (IG) or Antibodies and T Cell Receptors (TR): A Common Language for Immunoinformatics and Artificial Intelligence (AI).
  • 15 Apr 2026
  • Antibodies (Basel, Switzerland)
Development of a Human IgG1 Monoclonal Antibody Targeting Transferrin Receptor 1 for Antitumor Drug Delivery.
  • 13 Apr 2026
  • Antibodies (Basel, Switzerland)

FAQs on Antibodies